NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-69

  1. 915 Posts.
    lightbulb Created with Sketch. 254
    I can't believe the lack of volume after such big news . Day 2 after retts was 35 mill or so traded from memory
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.